longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

OCULIS HOLDING AG C/WTS 06/03/2028 (TO PUR ORD)

OCSAW

3.8300.00% ( 0.000 )
Closed: Sep 11, 16:00:00 (EDT)
Start trading
OverviewOverviewNewsNewsPostsPosts
LongbridgeAI

OCULIS HOLDING AG C/WTS 06/03/2028 (TO PUR ORD) (OCSAW)

Open
--
High
--
Low
--
Prev. Close
3.830
Volume
0
Turnover
0
Avg Price
--
Bid/Ask Ratio
--
Amplitude
--
52wk High
22.635
Volume Ratio
0.00
Turnover Ratio
--
52wk Low
3.630
Float Mkt Cap
200.74M
Market CapUSD
236.43M
P/ETTM
--
P/EDynamic
--
P/EStatic
--
EPSTTM
--
EPSDynamic
--
EPSStatic
--
BVPS
--
P/B
--
Circulating Supply
52.41M
Dividend YieldTTM
--
DividendTTM
--
Shares
61.73M
Min lot size
1
Currency
USD

News

  • Tip Ranks · May 12 at 06:55 AM

    Oculis Holding (OCS) Gets a Buy from Chardan Capital

  • Unusual Whales · May 12 at 12:21 AM

    Oculi Named as a 4th Batch of IC Taiwan Grand Challenge Winners

  • Tip Ranks · Apr 25 at 04:31 PM

    Oculis Advances Targeted Dry Eye Drug Licaminlimab Into Late-Stage Testing

  • Simplywall · Apr 21 at 06:07 AM

    Why Oculis Holding (OCS) Is Up 5.5% After Phase 3 DME Trial Milestone – And What's Next

  • Simplywall · Apr 4 at 05:48 PM

    Oculis Holding (OCS) Is Up 7.9% After EMA PRIME Tag For Optic Neuritis Drug Candidate

  • StockTitan · Mar 31 at 12:01 AM

    Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential First‑in‑Class Neuroprotective Candidate for Optic Neuritis | OCS Stock News